LA-A*1101-Restricted WT1 peptide and pharmaceutical composition comprising the same

Details for Australian Patent Application No. 2012227350 (hide)

Owner International Institute of Cancer Immunology, Inc.

Inventors Sugiyama, Haruo

Agent Davies Collison Cave

Pub. Number AU-A-2012227350

Parent 2007340679

Filing date 26 September 2012

Wipo publication date 18 October 2012

International Classifications

C12N 15/12 Mutation or genetic engineering - Genes encoding animal proteins

A61K 31/7088 - Compounds having three or more nucleosides or nucleotides

A61K 38/00 Medicinal preparations containing peptides

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 Antineoplastic agents

A61P 35/02 Antineoplastic agents

C07K 14/82 Peptides having more than 20 amino acids - Translation products from oncogenes

C12Q 1/02 Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

G01N 33/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

11 October 2012 Complete Application Filed

18 October 2012 Application Open to Public Inspection

  Published as AU-A-2012227350

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012227351-Dental hand tool with disinfectant reactor

2012227349-Therapy for alpha-galactosidase A deficiency